The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 23, 2018
Filed:
Jun. 03, 2014
Janssen Pharmaceutica NV, Beerse, BE;
Sergio-Alvar Alonso-de Diego, Toledo, ES;
José Maria Cid-Núñez, Toledo, ES;
Óscar Delgado-González, Santa Cruz de Tenerife, ES;
Annelies Marie Antonius Decorte, Berchem, BE;
Michiel Luc Maria Van Gool, Madrid, ES;
Gregor James MacDonald, Zoersel, BE;
Antonius Adrianus Hendrikus Petrus Megens, Beerse, BE;
Andrés Avelino Trabanco-Suárez, Olias del Rey (Toledo), ES;
Aránzazu Garcia-Molina, Toledo, ES;
José Ignacio Andrés-Gil, Madrid, ES;
Janssen Pharmaceutica NV, Beerse, BE;
Abstract
The present invention relates to novel 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives of formula (I) as negative allosteric modulators (NAMs) of the metabotropic glutamate receptor subtype 2 ('mGluR2') useful for the treatment of central nervous system disorders in which the mGluR2 subtype of metabotropic receptors is involved (e.g. mood disorder, schizophrenia, etc.). The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for treatment of central nervous system disorders in which the mGluR2 subtype of metabotropic receptors is involved.